PDF
File
Beskrivning
| Land | Danmark |
|---|---|
| Lista | First North Denmark |
| Sektor | Hälsovård |
| Industri | Vård & Omsorg |
Copenhagen, Denmark, 11 March 2025 - Brain+ A/S (Nasdaq First North: BRAINP)
Vishal Shah, a seasoned UK health and care entrepreneur, investor, and non-executive director, joins Brain+ as an Advisor and Board Observer. In this role, Vishal will support the strategic growth and expansion of Ayla, Brain+' cutting-edge dementia care solution, with a primary focus on the UK care home sector. Vishal brings extensive experience in healthcare investment, digital transformation, and operational healthcare in the care sector, making him a valuable addition to the Board of Directors. He is passionate about social care and community engagement, playing a key role in industry leadership through his positions at Care England and Championing Social Care. His commitment to charitable fundraising through adventure further reflects his dedication to supporting communities and improving lives. With the appointment of Vishal, Brain+ strengthens its strategic leadership, ensuring the company remains at the forefront of dementia care innovation, and his expertise in the UK care sector will be instrumental in accelerating Ayla's growth and impact.
Vishal joins at a point in time, where Brain+ is making significant commercial strides in the UK care home market, and next week, the company will provide an update on the status of its sales pipeline along with key performance indicators (KPIs) for 2025.
Brain+ A/S ("Brain+" or "the Company"), a pioneer in health tech solutions for better dementia management, is pleased to welcome Vishal Shah as an Advisor and Board Observer. Vishal brings a wealth of care sector and leadership expertise to Brain+, drawing from his extensive background in health and social care, including with SweetTree SPL and national providers Westminster Healthcare and Barchester. He is the Founder and Managing Director of Banyan Care, a Board Trustee and Treasurer of Care England-the leading representative body for independent care services-and serves as a Director and Care Ambassador for Championing Social Care. Additionally, he is a Board Member of Log My Care, an award-winning digital care platform. Vishal is an active investor in digital and technological innovations aimed at promoting longer, healthier, and happier lives, and has spoken at numerous industry confer ences on topics such as dementia care, social impact, digital innovation, and longevity investment.
Vishal will be proposed as new board member candidate at the next Annual General Meeting of Brain+ on 29 May 2025. His advisory role has already started with a focus on strategic guidance on the commercialisation of Ayla - your CST Assistant, providing invaluable insights into the UK care home sector to support awareness building, strengthen partnerships, and validate the impact of Brain+' dementia care solutions.
Vishal Shah, Advisor and Board Observer, Brain+, commented on his appointment:
"I am thrilled to join Brain+ at such an exciting time in its journey. The team's dedication to innovation in dementia care is inspiring, and I look forward to supporting their mission in delivering meaningful solutions that enhance care and quality of life into the health and care sector."
A strategic addition to Ayla's growth journey
Vishal has a strong track record in healthcare services, digital health, and real estate investment, with a particular focus on senior living and operational care environments. His expertise spans:
- Care Homes & Senior Living - Deep experience in scaling and developing healthcare services, operational real estate, and private equity-backed care businesses.
- Corporate Development & M&A - Successfully driving transformational change through mergers, acquisitions, and organic growth strategies.
- Digital Health & Innovation - Championing technology-driven solutions that improve health outcomes, care delivery, and operational efficiencies.
- Finance & Investment - Leading investment strategies and financial planning for high-growth healthcare and care sector businesses.
Upcoming update on UK sales pipeline progress and commercial KPIs for 2025
Brain+ will soon be sharing an update on the status of its UK sales pipeline for Ayla - your CST Assistant providing insight into the envisaged growth trajectory in dementia care. The Company will also share strategic milestones and commercial KPIs for 2025 building to attain its revenue target and meet the objective of operational break-even by mid 2026.
Contact Information
CEO and Co-founder, Kim Baden-Kristensen: + 45 31 39 33 17, kim@brain-plus.com
CFO, Hanne Vissing Leth: +45 53 88 99 02, hanne@brain-plus.com
Brain+ vision: Building the world's first scalable dementia care platform to help people affected by dementia, live better lives